MagForce AG and MagForce USA, Inc. Announce FDA Pre-IDE Meeting
May 05, 2014 03:09 ET
|
MagForce AG
BERLIN and Nevada, May 5, 2014 (GLOBE NEWSWIRE) -- MagForce AG (Frankfurt, Entry Standard, XETRA: MF6), a leading medical device company in the field of nanomedicine focused on oncology, together with...
MagForce AG publishes Shareholder Letter
March 31, 2014 12:38 ET
|
MagForce AG
BERLIN, March 31, 2014 (GLOBE NEWSWIRE) -- Dear MagForce Shareholders,
I am pleased to report that we achieved our 2013 targets and are progressing well toward achieving our objectives for the year...
Enrollment of the first patient in the MF 1001 glioblastoma study at the Muenster University Clinic
March 31, 2014 03:36 ET
|
MagForce AG
BERLIN, March 31, 2014 (GLOBE NEWSWIRE) -- MagForce AG (Frankfurt, Xetra: MF6), a leading medical technology company in the area of nanotechnology which focuses on oncology, today announced the...
MagForce AG Installs NanoActivator(r) at the Kiel University Hospital
December 19, 2013 09:57 ET
|
MagForce AG
Berlin, Germany, Dec. 19, 2013 (GLOBE NEWSWIRE) -- MagForce AG (Frankfurt, Xetra:MF6), a medical technology company that focuses on the field of oncology and is a leader in the nanotechnology sector,...
MagForce AG publishes Shareholder Letter
November 08, 2013 02:44 ET
|
MagForce AG
BERLIN, Nov. 8, 2013 (GLOBE NEWSWIRE) --
Dear MagForce Shareholders,
I am pleased to report that we are on target to achieve our 2013 plans:
Brain Cancer Therapy: Our main objective for 2013 is to...
MagForce AG Installs NanoActivator(r) at the University Hospital Munster
November 06, 2013 03:05 ET
|
MagForce AG
BERLIN, Germany, Nov. 6, 2013 (GLOBE NEWSWIRE) --
MagForce AG (Frankfurt, Xetra: MF6), a
medical technology company that focuses on the field of oncology and is a leader
in the nanotechnology sector,...
Stephan Jakober appointed to the Supervisory Board of MagForce AG
October 22, 2013 05:08 ET
|
MagForce AG
BERLIN, Germany, Oct. 22, 2013 (GLOBE NEWSWIRE) --
MagForce AG (Frankfurt, Xetra: MF6), a
leading medical device company in the area of nanotechnology with a focus on
oncology, today announced...
MagForce publishes 2013 Interim Report
September 30, 2013 06:53 ET
|
MagForce AG
BERLIN, Sept. 30, 2013 (GLOBE NEWSWIRE) --
* Capital increase of €33.5 million successfully completed
* New glioblastoma study approved by BfArM
* Ben J. Lipps new Chairman of the...